- Dominion Aesthetic Technologies, a Houston, TX-based medical device company, closed a $23.7M Series B financing
- The round led by Dominion Aesthetic Technologies’ CEO, Cooper Collins, with participation from Houston’s top biotechnology and medical device investors
- The company intends to use the funds to accelerate the manufacturing and commercialization of its EON
- The closing of this Series B round follows the relocation from San Antonio to its Houston headquarters this month
- The new corporate office, located within 5 minutes of the Houston Bush Intercontinental Airport, is in a Qualified Opportunity Zone
- Dominion Aesthetic Technologies is advancing EON, an FDA-cleared 1064 nm robotic laser device used for touchless, external non-invasive lipolysis of the abdomen
